Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drug-Receptor Interactions01:29

Drug-Receptor Interactions

5.1K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.1K
Drug-Receptor Interaction: Antagonist01:28

Drug-Receptor Interaction: Antagonist

2.9K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
2.9K
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

2.5K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.5K
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

361
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
361
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

8.4K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.4K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.9K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Comprehensive Review on Drug-target Interaction Prediction - Latest Developments and Overview.

Current drug discovery technologies·2023
Same author

Automating Drug Discovery using Machine Learning.

Current drug discovery technologies·2023
查看所有相关文章

相关实验视频

Updated: Jun 25, 2025

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.2K

一个用于药物相互作用的新型深度学习模型.

Ali K Abdul Raheem1,2, Ban N Dhannoon3

  • 1Department of Software, College of Information Technology, University of Babylon, Hillah, Babil, Iraq.

Current computer-aided drug design
|May 28, 2024
PubMed
概括

这项研究引入了一种新的方法,使用两个传递信息的神经网络 (MPNN) 模型来预测药物相互作用 (DDI). 该方法实现了高精度,通过更好的DDI预测,提高了患者安全和个性化医疗.

关键词:
药物相互作用 药物相互作用在GNN中,GNN是最重要的.MPNN MPNN 在线观看斯米尔斯的微笑深度学习是一种深度学习.一个模型.模型.

更多相关视频

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.5K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.8K

相关实验视频

Last Updated: Jun 25, 2025

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.2K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.5K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.8K

科学领域:

  • 计算化学是一种计算化学.
  • 药理学 药理学是指药理学的学科.
  • 医学中的人工智能.

背景情况:

  • 药物相互作用 (DDI) 带来风险,包括不良事件和治疗效果降低.
  • 准确的预测和对DDI的理解对于患者安全和有效的药物治疗至关重要.

研究的目的:

  • 提出和评估使用传递信息的神经网络 (MPNNs) 进行DDI预测的新方法.
  • 通过捕捉个体药物特征及其相互作用来提高DDI预测的准确性.

主要方法:

  • 开发了两个单独的MPNN模型,每个模型都专注于一对药物中的一种药物.
  • 来自单个MPNN的组合输出,以整合分子特征和相互作用信息.
  • 在一个全面的数据集上对模型进行了评估.

主要成果:

  • 实现了卓越的性能,精度为0.90,AUC为0.99,F1得分为0.80.
  • 证明了双MPNN方法在准确识别潜在的DDI方面的有效性.
  • 灵活的框架有助于理解药物特征和相互作用.

结论:

  • 拟议的双MPNN方法显示了提高DDI预测准确性的巨大潜力.
  • 这些发现对提高患者安全和推进个性化医疗具有重要意义.
  • 建议对更大的数据集和现实世界的场景进行进一步验证.